Significance of nuclear factor - kappa beta activation on prostate needle biopsy samples in the evaluation of Gleason score 6 prostatic carcinoma indolence

Zupancic, Marko; Pospihalj, Boris; Cerovic, Snezana; Gazic, Barbara; Drev, Primoz; Hocevar, Marko; Perhavec, Andraz

doi:10.2478/raon-2020-0019

References

Ferlay J, Colombet M, Soerjomataram I, Dyba T, Randi G, Bettio M, et al. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018. Eur J Cancer 2018; 103: 356-87. doi: 10.1016/j.ejca.2018.07.005.
Open DOI Search in Google Scholar Back to article
Luengo-Fernandez R, Leal J, Gray A, Sullivan R. Economic burden of cancer across the European Union: a population-based cost analysis. Lancet Oncol 2013; 14: 1165-74. doi: 10.1016/S1470-2045(13)70442-X.
Open DOI Search in Google Scholar Back to article
Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, et al. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 2004; 171: 1393-401. doi: 10.1097/01.ju.0000107247.81471.06
Open DOI Search in Google Scholar Back to article
Albertsen PC, Hanley JA, Fine J. 20-year outcomes following conservative management of clinically localized prostate cancer. JAMA 2005; 293: 2095101. doi: 10.1001/jama.293.17.2095
Open DOI Search in Google Scholar Back to article
Bangma CH, Roobol MJ. Defining and predicting indolent and low risk prostate cancer. Crit Rev Oncol Hematol 2012; 83: 235-41. doi: 10.1016/j.critrevonc.2011.10.003
Open DOI Search in Google Scholar Back to article
Karin M, Lin A. NF-κB at the crossroads of life and death. Nat. Immunol 2002; 3: 221-7. doi: 10.1038/ni0302-221
Open DOI Search in Google Scholar Back to article
May MJ, Ghosh S. Rel/NF-kappa B and I kappa B proteins: an overview. Semin Cancer Biol 1997; 8: 63-73. doi: 10.1006/scbi.1997.0057
Open DOI Search in Google Scholar Back to article
Lessard L, Karakiewicz PI, Bellon-Gagnon P, Alam-Fahmy M, Ismail HA, Mes-Masson AM, et al. Nuclear localization of nuclear factor-kappaB p65 in primary prostate tumors is highly predictive of pelvic lymph node metastases. Clin Cancer Res 2006; 12: 5741-5. doi: 10.1158/1078-0432.CCR-06-0330
Open DOI Search in Google Scholar Back to article
Domingo-Domenech J, Mellado B, Ferrer B, Truan D, Codony-Servat J, Sauleda S, et al. Activation of nuclear factor-kappaB in human prostate carcinogenesis and association to biochemical relapse. Br J Cancer 2005; 93: 1285-94. doi: 10.1038/sj.bjc.6602851
Open DOI Search in Google Scholar Back to article
Ross JS, Kallakury BV, Sheehan CE, Fisher HA, Kaufman RP Jr, Kaur P, et al. Expression of nuclear factor-kappa B and I kappa B alpha proteins in prostatic adenocarcinomas: correlation of nuclear factor-kappa B immuno-reactivity with disease recurrence. Clin Cancer Res 2004; 10: 2466-72. doi: 10.1158/1078-0432.ccr-0543-3
Open DOI Search in Google Scholar Back to article
Setlur SR, Royce TE, Sboner A, Mosquera JM, Demichelis F, Hofer MD, et al. Integrative microarray analysis of pathways dysregulated in metastatic prostate cancer. Cancer Res 2007; 67: 10296-303. doi: 10.1158/1078-0432. ccr-0543-3
Open DOI Search in Google Scholar Back to article
Park MH, Hong JT. Roles of NF-κB in cancer and inflammatory diseases and their therapeutic approaches. Cells 2016; 5: E15. doi: 10.3390/cells5020015.
Open DOI Search in Google Scholar Back to article
Lessard L, Begin LR, Gleave ME, Mes-Masson AM, Saad F. Nuclear localisation of nuclear factor-kappaB transcription factors in prostate cancer: an immunohistochemical study. Br J Cancer 2005; 93: 1019-23. doi: 10.1038/sj.bjc.6602796
Open DOI Search in Google Scholar Back to article
Gannon PO, Lessard L, Stevens LM, Forest V, Bégin LR, Minner S, et al. Large-scale independent validation of the nuclear factor-kappa B p65 prognostic biomarker in prostate cancer. Eur J Cancer 2013; 49: 2441-8. doi: 10.1016/j. ejca.2013.02.026
Open DOI Search in Google Scholar Back to article
Ganz PA, Barry JM, Burke W, Col NF, Corso PS, Dodson E, et al. NIH State-of-the-Science Conference Statement: role of active surveillance in the management of men with localized prostate cancer. NIH Consens State Sci Statements 2011; 28: 1-27. PMID: 23392076
Search in Google Scholar Back to article
Lucia MS, Bostwick DG, Somerville MC, Fowler IL, Rittmaster RS. Comparison of classic and international society of urological pathology 2005 modified Gleason grading using needle biopsies from the reduction by dutasteride of prostate cancer events (REDUCE) trial. Arch Pathol Lab Med 2013; 137: 1740-6. doi: 10.5858/arpa.2012-0447-OA
Open DOI Search in Google Scholar Back to article
Komisarenko M, Martin LJ, Finelli A. Active surveillance review: contemporary selection criteria, follow-up, compliance and outcomes. Transl Androl Urol 2018; 7: 243-55. doi: 10.21037/tau.2018.03.02
Open DOI Search in Google Scholar Back to article
McCormick BZ, Mahmoud AM, Williams SB, Davis JW. Biochemical recurrence after radical prostatectomy: Current status of its use as a treatment endpoint and early management strategies. Indian J Urol 2019; 35: 6-17. doi: 10.4103/iju.IJU_355_18
Open DOI Search in Google Scholar Back to article

Significance of nuclear factor - kappa beta activation on prostate needle biopsy samples in the evaluation of Gleason score 6 prostatic carcinoma indolence

References

Paradigm

My account